Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» M&A
M&A
'Far too speculative': Amgen fights FTC's request for injunction against $28B Horizon merger
Fierce Pharma
Thu, 08/24/23 - 11:38 am
Amgen
Horizon Therapeutics
M&A
FTC
LEO Pharma to Acquire Timber Pharmaceuticals
Dermatology Times
Mon, 08/21/23 - 07:58 pm
LEO Pharma
M&A
Timber Pharmaceuticals
dermatology
Stada CEO Confirms Buyout Rumors, Sale Could Potentially Fetch $11B
BioSpace
Wed, 08/16/23 - 11:35 am
Stada
M&A
Peter Goldschmidt
How Biogen outbid a rival 'large-cap' pharma to claim Reata for $7.3B
Fierce Pharma
Tue, 08/15/23 - 11:53 am
Biogen
Reata Pharmaceuticals
M&A
Skyclarys
Friedreich’s ataxia
Harmony Makes Rare Disease Play with Potential $200M Zynerba Buyout
BioSpace
Tue, 08/15/23 - 11:36 am
Harmony Biosciences
Zynerba
M&A
neuropsychiatric
Eli Lilly and Company completes acquisition of Versanis Bio
Pharmaceutical Business Review
Tue, 08/15/23 - 10:01 am
Eli Lilly
Versanis Bio
M&A
SEC Investigating Illumina’s Multi-Billion Dollar Merger with GRAIL
BioSpace
Fri, 08/11/23 - 11:40 am
SEC
Illumina
Grail
M&A
cancer
diagnostics
Novo Nordisk bets $1.1B on Canadian biotech buyout, adding an old approach to obesity pipeline
Fierce Biotech
Thu, 08/10/23 - 11:41 am
Novo Nordisk
M&A
obesity
Inversago
Could This $6.5 Billion Acquisition Help Turn Biogen's Business Around?
Motley Fool
Thu, 08/10/23 - 09:57 am
Biogen
Reata Pharmaceuticals
M&A
Skyclarys
Proposed Merger Is a Match Made in AI
Medical Devices and Diagnostics Industry
Wed, 08/9/23 - 10:30 pm
Renovaro BioSciences
Gedi Cube
M&A
artificial intelligence
Regeneron adds Decibel to gene therapy playlist, turning up volume on long-running hearing loss collaboration
Fierce Biotech
Wed, 08/9/23 - 10:10 am
Regeneron
hearing loss
Decibel Therapeutics
gene therapy
M&A
Bausch + Lomb's Saunders doesn't expect more big deals in the near term
Reuters
Fri, 08/4/23 - 10:19 am
Bausch + Lomb
Pharma CEOs
Brent Saunders
earnings
M&A
Biogen looks at selling biosims unit to longtime ally Samsung Bioepis: reports
Fierce Pharma
Thu, 08/3/23 - 09:59 am
Biogen
biosimilars
M&A
Samsung Bioepis
Surface warns bankruptcy possible if shareholders reject Coherus merger
Fierce Biotech
Wed, 08/2/23 - 10:39 am
Surface Onolcogy
Coherus Biosciences
M&A
bankruptcy
Merck still scouting for M&A deals, even after $10.8B takeover of Prometheus
Fierce Pharma
Tue, 08/1/23 - 10:19 pm
Merck
Prometheus Biosciences
M&A
Biogen's Just Made Its Biggest Acquisition. Here's What You Need to Know.
Motley Fool
Tue, 08/1/23 - 11:55 am
Biogen
Reata Pharmaceuticals
M&A
Big Pharma CEOs get candid about pricing and M&A
Pharma Voice
Mon, 07/31/23 - 10:03 am
Big Pharma
Pharma CEOs
drug pricing
M&A
JNJ
Merck
GSK
Biogen to acquire rare disease drugmaker Reata for $7.3B
BioPharma Dive
Fri, 07/28/23 - 11:50 am
Biogen
Reata Pharmaceuticals
M&A
Friedreich's Ataxia
AstraZeneca buys Pfizer’s early gene therapy work for up to $1B
BioPharma Dive
Fri, 07/28/23 - 10:45 am
AstraZeneca
Pfizer
M&A
gene therapy
Gene editing biotech Homology hits reset and seeks a sale
BioPharma Dive
Fri, 07/28/23 - 10:35 am
Homology
PKU
gene editing
M&A
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »